Skip to main content
Log in

Expression of cyclooxygenase-2 and thromboxane synthase in non-neoplastic and neoplastic thyroid lesions

  • Clinical Research
  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Cyclooxygenase-2 (COX-2) and thromboxane synthase (TBXAS) are important enzymes involved in the arachidonic acid pathway and synthesis of prostaglandins. We examined COX-2 and TBXAS immunoreactivity in 150 surgically resected thyroid specimens using immunohistochemistry to determine expression in benign and malignant thyroid lesions and to examine their roles in thyroid tumor progression. Papillary thyroid carcinomas and follicular carcinomas expressed higher levels of COX-2 compared to follicular adenomas and adenomatous nodules. We showed for the first time that TBXAS was expressed in thyroid tissues, with higher levels in papillary carcinomas compared to non-neoplastic and benign thyroid tissues. Western blot was performed on seven thyroid samples.

These results indicate that both COX-2 and TBXAS are expressed in benign and malignant thyroid tissues. Although some malignant thyroid tumors showed higher levels of COX-2 expression, COX-2 and TBXAS are probably not useful in the immunohistochemical diagnosis of thyroid malignancies. However, the expression of both COX-2 and TBXAS by thyroid tissue may provide insight into the role of these enzymes in progression from benign to malignant thyroid tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Herschman HR. Prostaglandin synthase 2. Biochim Biophys Acta 1299:125–140, 1996.

    PubMed  Google Scholar 

  2. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach, S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183–1188, 1994.

    PubMed  CAS  Google Scholar 

  3. Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57:1276–1280, 1997.

    PubMed  CAS  Google Scholar 

  4. Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of inducible nitric oxide and cyclooxygenase-2 in Barrett’s esophagus and associated adenocarcinomas. Cancer Res 58:2929–2934, 1998.

    PubMed  CAS  Google Scholar 

  5. Hida T, Yatabe Y, Achiwa H, et al. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 58:3761–3764, 1998.

    PubMed  CAS  Google Scholar 

  6. Komhoff M, Guan Y, Shappell HW, et al. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. Am J Pathol 157:29–53, 2000.

    PubMed  CAS  Google Scholar 

  7. Tucker ON, Dannenberg AJ, Yank EK, et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 59:987–990, 1999.

    PubMed  CAS  Google Scholar 

  8. Karim MM, Hayashi Y, Inoue M, Imai Y, Ito H, Yamamoto M. COX-2 expression in ret-inoblastoma. Am J Ophthalmol 129:398–401, 2000.

    Article  PubMed  CAS  Google Scholar 

  9. Shamma A, Yamamoto H, Doki Y, et al. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Clin Cancer Res 6:1229–1238, 2000.

    PubMed  CAS  Google Scholar 

  10. Yoshimura R, Sano H, Masuda C, et al. Expression of cyclooxygenase-2 in prostate carcinoma. Cancer 89:589–596, 2000.

    Article  PubMed  CAS  Google Scholar 

  11. Joki T, Heese O, Nikas DC, et al. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 60:4926–4931, 2000.

    PubMed  CAS  Google Scholar 

  12. Kulkarni S, Rader JS, Zhang F, et al. Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin Cancer Res 7:429–434, 2001.

    PubMed  CAS  Google Scholar 

  13. Denkert C, Kobel M, Berger S, et al. Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res 61:303–308, 2001.

    PubMed  CAS  Google Scholar 

  14. Castilla EA, Prayson RA, Kanner AA, et al. Cyclooxygenase-2 in oligodendroglial neoplasms. Cancer 98:1465–1472, 2003.

    Article  PubMed  CAS  Google Scholar 

  15. Bing RJ, Miyataka M, Rich KA, et al. Nitric oxide, prostanoids, cyclooxygenase and angiogenesis in colon and breast cancer. Clin Cancer Res 7:3385–3392, 2001.

    PubMed  CAS  Google Scholar 

  16. Cornetta AJ, Russell JP, Cunnane M, Keane WM, Rothstein JL. Cyclooxygenase-2 expression in human thyroid carcinoma and Hashimoto’s thyroiditis. Laryngoscope 112:238–242, 2002.

    Article  PubMed  CAS  Google Scholar 

  17. Specht MC, Tucker ON, Hocerer M, Gonzalez D, Tery L, Fahes TJ. Cyclooxygenase-2 expression in thyroid nodules. J Clin Endocrinol Metab 87:358–363, 2002.

    Article  PubMed  CAS  Google Scholar 

  18. Hamberg M, Samuelsson B. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci USA 71:3400–3404, 1974.

    Article  PubMed  CAS  Google Scholar 

  19. Moncada S, Vane JR. Drugs that modulate prostaglandins, prostacyclin, and thromboxane A2. Drug Ther 37–65, 1982.

  20. Ogletree ML. Overview of physiological and pathophysiological effects of thromboxane A2. Fed Proc 46:133–138, 1987.

    PubMed  CAS  Google Scholar 

  21. Zhang L, Chase MB, Shen RF. Molecular cloning and expression of murine thromboxane synthase. Biochem Biophys Res Commun 194:741–748, 1993.

    Article  PubMed  CAS  Google Scholar 

  22. Shen RF, Zhang L, Baek SJ, Tai HH, Lee KD. The porcine thromboxane synthase-encoding cDNA: sequence, mRNA expression and enzyme production in Sf9 insect cells. Gene 140:261–265, 1994.

    Article  PubMed  CAS  Google Scholar 

  23. Tone Y, Miyata A, Hara S, Yukawa S, Tanabe T. Abundant expression of thromboxane synthase in rat macrophages. FEBS Lett 340:241–244, 1994.

    Article  PubMed  CAS  Google Scholar 

  24. Honn KV, Busse WD, Sloane BF. Prostacyclin and thromboxanes. Implications of their role in tumor cell metastasis. Biochem Pharmacol 32:1–11, 1983.

    Article  PubMed  CAS  Google Scholar 

  25. Honn KV, Meyer J, Neagos G, Henderson T, Westley C, Ratanatharathorn V. Control of tumor growth and metastasis with prostacyclin and thromboxane synthetase inhibitors: evidence for a new antitumor and antimetastatic agent (BAY g6575). Prog Clin Biol Res 89:295–331, 1982.

    PubMed  CAS  Google Scholar 

  26. Drago JR, Al-Mondhiry HA. The effect of prostaglandin modulators on prostate tumor growth and metastasis. Anticancer Res 4:391–394, 1984.

    PubMed  CAS  Google Scholar 

  27. McDonough W, Tran N, Giese A, Norman SA, Berens ME. Altered gene expression in human astrocytoma cells selected for migration: I. Thromboxane synthase. J Neuropathol Exp Neurol 48:449–455, 1998.

    Google Scholar 

  28. Giese A, Hagel C, Kim EL, et al. Thromboxane synthase regulates the migratory phenotype of human glioma cells. Neuro-oncol 1:3–13, 1999.

    Article  PubMed  CAS  Google Scholar 

  29. Kurzel F, Hagel CH, Zapt S, Meissner H, Westphal M, Giese A. Cyclooxygenase inhibitors and thromboxane synthase inhibitors differentially regulate migration arrest, growth inhibition and apoptosis in human glioma cells. Acta Neurochir (Wien) 144:71–87, 2002.

    Article  CAS  Google Scholar 

  30. Pradono P, Tazawa R, Maemondo M, et al. Gene transfer of thromboxane A2 synthase and prostaglandin 12 synthase antithetically altered tumor angiogenesis and tumor growth. Cancer Res 62:63–66, 2002.

    PubMed  CAS  Google Scholar 

  31. Jin L, Zhang S, Bayliss J, et al. Chromogranin A processing in human pituitary adenomas and carcinomas: analysis and region-specific antibodies. Endocr Pathol 14:37–48, 2003.

    Article  PubMed  CAS  Google Scholar 

  32. Riss D, Jin L, Qian X, et al. Differential expression of galectin-3 in pituitary tumors. Cancer Res 63:2251–2255, 2003.

    PubMed  CAS  Google Scholar 

  33. Di Paola R, Menzaghi C, de Filippis V, Corda D, di Cerbo A. Cyclooxygenase-dependent thyroid cell proliferation induced by immunoglobulins from patients with Graves’ disease. J Clin Endocrinol Metab 82:670–673, 1997.

    Article  PubMed  Google Scholar 

  34. Berg J, Stocher M, Bogner S, Wolfl S, Pichler R, Stekel H. Inducible cyclooxygenase-2 gene expression in the human thyroid cell line Nthy-ori3-1. Inflamm Res 49:139–143, 2000.

    Article  PubMed  CAS  Google Scholar 

  35. Jones, MK, Wang H, Peskar BM, et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 5:1418–1423, 1999.

    Article  PubMed  CAS  Google Scholar 

  36. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93:705–816, 1998.

    Article  PubMed  CAS  Google Scholar 

  37. Daniel TO, Liu H, Morrow JD, Crews BC, Marnett LJ. Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res 59:4574–4577, 1999.

    PubMed  CAS  Google Scholar 

  38. Masferrer JL, Leahy KM, Koki AT, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 60:1306–1311, 2000.

    PubMed  CAS  Google Scholar 

  39. Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 105:1589–1594, 2000.

    Article  PubMed  CAS  Google Scholar 

  40. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94:3336–3340, 1997.

    Article  PubMed  CAS  Google Scholar 

  41. Kim HS, Youm HR, Lee JS, Min KW, Chung JH, Park CS. Correlation between cyclooxygenase-2 and tumor angiogenesis in nonsmall cell lung cancer. Lung Cancer 42(2):163–170, 2003.

    Article  PubMed  Google Scholar 

  42. Kong G, Kim EK, Kim WS, et al. Role of cyclooxygenase-2 and inducible nitric oxide synthase in pancreatic cancer. J Gastroenterol Hepatol 17(8):914–921, 2002.

    Article  PubMed  CAS  Google Scholar 

  43. Raspollini MR, Amunni G, Villanucci A, et al. COX-2 status in relation to tumor microvessel density and VEGFexpression: analysis in ovarian carcinoma patients with low versus high survival rates. Oncol Rep 11(2):309–313, 2004.

    PubMed  CAS  Google Scholar 

  44. Leung WK, To KF, Go MY, et al. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma. Int J Oncol 23(5):1317–1322, 2003.

    PubMed  CAS  Google Scholar 

  45. Xiong B, Sun TJ, Yuan HY, Hu MB, Hu WD, Cheng FL. Cyclooxygenase-2 expression and angiogenesis in colorectal cancer. World J Gastroenterol 9(6):1237–1240, 2003.

    PubMed  CAS  Google Scholar 

  46. Kase S, Osaki M, Honjo S, et al. Expression of cyclooxygenase 2 is correlated with high intratumoral microvessel density and low apoptotic index in human esophageal squamous cell carcinomas. Virchows Arch 442(2):129–135, 2003.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mary B. Casey MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Casey, M.B., Zhang, S., Jin, L. et al. Expression of cyclooxygenase-2 and thromboxane synthase in non-neoplastic and neoplastic thyroid lesions. Endocr Pathol 15, 107–115 (2004). https://doi.org/10.1385/EP:15:2:107

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/EP:15:2:107

Key Words

Navigation